Literature DB >> 35170826

Orchestrated expression of vasculogenic mimicry and laminin-5γ2 is an independent prognostic marker in oral squamous cell carcinoma.

Depanwita Saha1, Debarpan Mitra1, Neyaz Alam2, Sagar Sen2, Saunak Mitra Mustafi3, Syamsundar Mandal4, Biswanath Majumder5, Nabendu Murmu1.   

Abstract

Vasculogenic mimicry (VM), an endothelial cell-independent alternative mechanism of blood supply to the malignant tumour, has long been considered as an adverse prognostic factor in many cancers. The correlation of VM with laminin-5γ2 and the assessment of their harmonized expression as an independent risk factor have not been elucidated yet in oral squamous cell carcinoma (OSCC). CD31/PAS staining stratified 116 clinically diagnosed OSCC specimens into VM+ and VM- cohorts. The expression pattern of laminin-5γ2 and its upstream modulator MMP2 was evaluated by immunohistochemistry and Western blot. The Kaplan-Meier and Cox regression analyses were performed to assess the survival and prognostic implications. The presence of VM demonstrated a significant correlation with the expression of laminin-5γ2 (p < .001) and MMP2 (p < .001). This pattern was mirrored by the significant upregulation of laminin-5γ2 and MMP2 in VM+ cohorts compared with the VM- ones. Furthermore, co-expression of VM and laminin-5γ2 was significantly associated with tumour grade (p = .010), primary tumour size (p < .001), lymph node metastasis (p = .001) and TNM stages (p < .001) but not with patients' age, gender, tobacco and alcohol consumption habit. Vasculogenic mimicry and laminin-5γ2 double-positive cohort displayed a significantly poorer disease-free survival (DFS) and overall survival (OS). Vasculogenic mimicry, laminin-5γ2 and their subsequent dual expression underlie a significant prognostic value for DFS [hazard ratio (HR) = 9.896, p = .028] and OS [HR = 21.401, p = .033] in OSCC patients. Together, our findings imply that VM along with laminin-5γ2 is strongly linked to the malignant progression in OSCC and VM and laminin-5γ2 coordination emerges as a critical prognostic biomarker for OSCC.
© 2022 Company of the International Journal of Experimental Pathology (CIJEP).

Entities:  

Keywords:  OSCC; co-expression; laminin-5γ2; prognosis; survival; vasculogenic mimicry

Mesh:

Substances:

Year:  2022        PMID: 35170826      PMCID: PMC8961501          DOI: 10.1111/iep.12430

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  66 in total

Review 1.  Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis.

Authors:  Zhifei Cao; Meimei Bao; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang; Quansheng Zhou
Journal:  Eur J Cancer       Date:  2013-08-27       Impact factor: 9.162

2.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

3.  Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.

Authors:  Baocun Sun; Shiwu Zhang; Danfang Zhang; Jing Du; Hua Guo; Xiulan Zhao; Wei Zhang; Xishan Hao
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

4.  Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry.

Authors:  Navesh Sharma; Richard E B Seftor; Elisabeth A Seftor; Lynn M Gruman; Paul M Heidger; Michael B Cohen; David M Lubaroff; Mary J C Hendrix
Journal:  Prostate       Date:  2002-02-15       Impact factor: 4.104

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

6.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Orchestrated expression of vasculogenic mimicry and laminin-5γ2 is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Syamsundar Mandal; Biswanath Majumder; Nabendu Murmu
Journal:  Int J Exp Pathol       Date:  2022-02-16       Impact factor: 1.925

Review 8.  Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.

Authors:  Daniel Delgado-Bellido; Santiago Serrano-Saenz; Mónica Fernández-Cortés; F Javier Oliver
Journal:  Mol Cancer       Date:  2017-03-21       Impact factor: 27.401

9.  Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation.

Authors:  Bing Zhao; Mengfang Wu; Zhihuang Hu; Yixin Ma; Wang Qi; Yanling Zhang; Yaran Li; Min Yu; Huijie Wang; Wei Mo
Journal:  Signal Transduct Target Ther       Date:  2020-07-10

10.  Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.

Authors:  Guo-Rung You; Ann-Joy Cheng; Li-Yu Lee; Yu-Chen Huang; Hsuan Liu; Yin-Ju Chen; Joseph T Chang
Journal:  BMC Cancer       Date:  2019-01-14       Impact factor: 4.430

View more
  2 in total

1.  Orchestrated expression of vasculogenic mimicry and laminin-5γ2 is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Syamsundar Mandal; Biswanath Majumder; Nabendu Murmu
Journal:  Int J Exp Pathol       Date:  2022-02-16       Impact factor: 1.925

2.  Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Pradip K Majumder; Biswanath Majumder; Nabendu Murmu
Journal:  J Cell Commun Signal       Date:  2022-09-05       Impact factor: 5.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.